Position in VCYT
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,008,559
+$808,223 QoQ
Shares Held
31,312
+518.9% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VCYT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026HRT FINANCIAL LP holds $56,167,229 across 14 Diagnostics & Research names. VCYT ranks #8 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
177,683 | $33,688,696 | |
| 2 | MYGN |
Myriad Genetics Inc
|
1,786,319 | $8,038,435 | |
| 3 | MEDP |
Medpace Holdings, Inc.
|
7,571 | $3,635,518 | |
| 4 | QGEN |
Qiagen N.V.
|
72,302 | $2,894,972 | |
| 5 | SHC |
Sotera Health Co
|
139,192 | $1,996,013 | |
| 6 | ADPT |
Adaptive Biotechnologies Corp
|
131,241 | $1,821,625 | |
| 7 | PSNL |
Personalis, Inc.
|
208,891 | $1,330,635 | |
| 8 | VCYT |
Veracyte, Inc.
This page
|
31,312 | $1,008,559 |
All Filings in VCYT
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,008,559 | 31,312 | Shares | Defined | 2026-05-14 | |
| 2024-12-31 | $200,336 | 5,059 | Shares | Defined | 2025-02-14 | |
| 2023-03-31 | $1,251,832 | 56,136 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,114,983 | 89,127 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $466,875 | 28,125 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||